Cardiac POC Testing Devices Market
Cardiac POC Testing Devices Market Analysis By Product (Cardiac Markers Test & Analyzers) By End-User (Hospitals & Laboratories, Clinics, Diagnostic Centers & Others) and By Region – Global Market Insights 2022 to 2026
Analysis of Cardiac POC Testing Devices market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Cardiac POC Testing Devices Market Outlook (2022 to 2026)
Worldwide sales of cardiac POC testing devices are anticipated to increase rapidly at a CAGR of 6% from 2022 to 2026. In 2022, the global cardiac POC testing devices market is valued at US$ 1.5 billion and is projected to reach a market size of US$ 1.9 billion by 2026.
Demand for cardiac markers testing is expected to rise at 6.2% CAGR over the forecast period. The introduction of quick and novel biomarker testing, as well as strong research and development on cardiovascular treatments, are factors expected to fuel market expansion. When compared to traditional laboratory-based testing, cardiac markers testing offers a quicker diagnosis.
Report Attributes | Details |
---|---|
Cardiac POC Testing Devices Market Size (2022) | US$ 1.5 Billion |
Projected Market Value (2026) | US$ 1.9 Billion |
Global Market Growth Rate (2022 to 2026) | 6% CAGR |
Market Share of Cardiac Markers Test | 70% |
Key Companies Profiled | LifeSign LLC; Medtronic plc; Nano-Ditech Corporation; Nexus Dx, Inc.; PTS Diagnostics; Bio-Rad Laboratories, Inc.; F. Hoffmann-La Roche AG; Nova Biomedical Corporation; Danaher Corporation; Sekisui Medical Co., Ltd. |
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Revenue Analysis of Cardiac POC Testing Devices (2017 to 2021) Vs. Market Predictions (2022 to 2026)
“Increasing Need for Cardiac POC Testing Devices to Assess Health of Patients Exhibiting Symptoms of Heart Problems”
According to Fact.MR, a market research and competitive intelligence provider, the cardiac POC testing devices market is projected to increase at a CAGR of 6% from 2022 to 2026.
Devices used for point-of-care testing are those that are utilised for medical diagnostic procedures where the test is carried out where and when the patient is receiving care. These testing tools help patients save time because it takes a while to send samples to the lab and wait for the results.
Many Cardiac POC diagnostic kits are utilised for diagnostic procedures in medicine. The timing and location of these examinations are suitable for the care of the patients. POC testing is also a blood diagnostic method used to identify problems with blood coagulation and cholesterol.
Cardiac POC test kits provide correct results quickly and affordably, and they are standardized to reduce operational errors. The increasing shift towards efficient and value-based healthcare service delivery is also supporting the market growth.
Many medical professionals choose POC cardiac testing to promptly assess the health of patients exhibiting symptoms of a heart problem in emergency care settings, such as chest discomfort or other symptoms.
Why is the Popularity of Cardiac POC Testing Devices Rising at a Rapid Pace?
“Technological Innovations in Cardiovascular Therapies Driving Demand for Cardiac POC Testing Systems”
The increasing requirement for rapid POC tests for the early diagnosis of infections or heart disorders is predicted to propel the market expansion. As the world's population ages, more people are projected to suffer from cardiac problems, which is expected to drive the demand for cardiac POC testing equipment over the forecast period.
Rising investments in research and development activities for the innovation in cardiac POC testing technologies driving market expansion. The essential aspect accelerating the market growth is the rise in spending by government organizations to support enhanced healthcare facilities.
Additionally, the market for cardiac point-of-care testing kits will see new opportunities as a result of the growing modernization and recent advances in the healthcare industry.
The expansion of POC solutions in environments with constrained resources is anticipated to be significantly impacted by the integration of digital technology. The need to integrate technologies that enable simple networking is driven by the growing significance of POC diagnostics in environmental monitoring and public health. This will make it even easier for healthcare providers to correctly interpret test findings.
The expanding technological innovations in cardiovascular therapies have significantly contributed to boosting the growth of the global market over the coming years. With these developments, businesses and healthcare institutions are better able to provide patients with high-tech solutions that meet their changing needs. Thus, this has contributed to the global market for cardiac POC testing devices expanding.
The use of cutting-edge technologies, rising R&D expenditures, and growing emphasis on patient-centric care solutions are just a few of the key drivers that will propel the market expansion over the coming years.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
What’s Hampering the Sales of Cardiac POC Testing Devices?
“Lack of Accuracy in Quick POC Diagnostic Tests & Stringent Government Regulations Denting Market Growth”
The main factor impeding the expansion of the global market is the unreliable results produced by cardiac POC testing devices. Point-of-care testing may be advantageous in urgent situations requiring quick test findings for clinical evaluation. However, there are many drawbacks to point-of-care testing, mostly related to quality control.
While point-of-care testing is typically carried out by untrained workers as well as patients themselves, laboratory tests are carried out by trained specialists who ensure accurate results. As a result, there may be fluctuations in the test's results due to a lack of accuracy, which would hinder the point of care diagnostics market expansion.
Another factor impeding market expansion is the strict regulatory requirements for the approval of new devices. The regulatory agencies have recently implemented many changes to address the lack of standardization in the device portfolio, which causes lengthy product approval processes and, as a result, hinders the market for cardiac POC testing devices.
The high cost of the viral clearing technology and rising costs for point-of-care diagnostic tools are hampering the market growth.
How Can Start-ups Establish Their Position in the Cardiac POC Testing Devices Industry?
“Aspiring Market Players Focusing on Developing Effective Production Processes and Introduction of Advanced Products”
Biochips that respond to the components in the sample make it possible to diagnose conditions connected to the heart, fertility, and other conditions. As biochips and biosensors are used in healthcare applications, including wearable and point-of-care, new companies are developing more effective production processes.
Additionally, new market entrants are creating advanced biochips that can identify a wider variety of biomarkers and characteristics for a variety of health tests.
- A Cypriot start-up called Bioloom develops high-sensitivity biochips using unique plasmonic interferometric sensors. Small volumes of liquid can be tested on the sensing region of the micrometer-scale biosensor. Currently, the company is developing biochips to identify sepsis and anaphylaxis.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Which Region is Expected to Lead Market Expansion Going Forward?
“Increasing R&D Investments by Governments for Production of Innovative POC Diagnostic Testing Devices in North America”
North America accounts for the highest share in the global market due to the rising prevalence of cardiovascular disorders as well as the availability of attractive reimbursement policies.
Increasing R&D investments by the government to support the diagnostics industry for the production of the most innovative point-of-care diagnostic testing devices and the presence of key suppliers of cardiac POC testing devices are driving market growth in North America.
Country-wise Insights
Why is the Market for Cardiac POC Testing Devices So Prominent in the U.S?
“Growing Usage of Advanced POC Diagnostics to Identify Various Infectious & Chronic Diseases”
Factors propelling the market expansion in the U.S. are the rise in the use of early illness detection procedures, growing awareness among physicians and patients regarding the use of cardiac POC testing devices, and the growing usage of cardiac testing.
The market in the U.S. is projected to grow due to the widespread use of advanced point-of-care diagnostics to identify a variety of infectious and chronic diseases.
What’s Driving Demand for Cardiac POC Testing Devices in China?
“Growing Public Awareness about Cardiac Diagnosis & Treatment in China”
The cardiac POC testing devices market in China is anticipated to rise at a CAGR of 7% from 2022 to 2026. The expansion of the market in China is being fuelled by advancements in cardiac POC testing devices, increased government spending on healthcare facilities, and advanced product offerings by key companies.
Increasing use of new technologies by hospitals and diagnostic labs, and increased public knowledge of cardiac diagnosis and treatment are driving the market growth in China.
Category-wise Insights
Which Cardiac POC Testing Product Will Enjoy Higher Sales Growth?
“Cardiac Markers Testing Widely Used for Indicating Abnormality of Cardiac Functioning”
Based on product, the cardiac POC testing devices market is classified into cardiac markers test and analyzers. The cardiac markers test segment accounts for 70% share of the global market.
A significant contributing factor to the rising popularity of cardiac markers testing is the increased accuracy of the evaluation of cardiac problems based on blood cardiac biomarkers. The demand for point-of-care cardiac markers is expected to rise due to the growing consumer awareness and rising use of cardiac kits.
Using cardiac biomarker testing to monitor heart abnormalities to prevent cardiac diseases is an innovative method for obtaining speedy results that may be applied to the early diagnosis and treatment of cardiac illnesses.
Which End User is Expected to Generate High Revenue for Market Players?
“Wide Accessibility of Innovative Diagnostic Systems in Diagnostic Centers”
Based on end user, the market is segmented into hospitals & laboratories, clinics, diagnostic centers, and others. The largest share of the global cardiac POC testing devices market is held by diagnostic centers.
The wide accessibility of innovative diagnostic technologies and the rising number of diagnostic centers and laboratories are boosting the sales of cardiac POC testing devices in diagnostic centers.
The segment growth is attributed to the rising adoption of modern instruments and rapid integration of technologically advanced analysis equipment.
In addition, growing patient awareness about the early detection and prevention of diseases and the increasing prevalence of cardiovascular diseases are some other factors driving the demand for cardiac POC testing devices in diagnostic centers.
Competitive Landscape
Key market participants are oriented toward the accuracy of the tests based on the detection of cardiac POC testing devices and are focused on attaining expansion via the development of novel product designs and new tests.
For instance :
- PTS Diagnostics recently disclosed a partnership with renowned healthcare contract sales firm MedPro Healthcare Sales Solutions.
Segments of Cardiac POC Testing Devices Industry Research
-
By Product :
- Cardiac Markers Test
- Analyzers
-
By End User :
- Hospitals & Laboratories
- Clinics
- Diagnostic Centers
- Others
-
By Region :
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Table of Content
- 1. Executive Summary
- 2. Market Overview
- 3. Key Market Trends
- 4. Key Success Factors
- 5. Market Background
- 6. Global Market Drivers and Restraints
- 7. Global Market Volume (Units) Analysis 2017 to 2021 and Forecast, 2022 to 2026
- 8. Global Market - Pricing Analysis
- 9. Global Market Value Analysis 2017 to 2021 and Forecast, 2022 to 2026
- 10. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2026, by Product
- 10.1. Cardiac Markers Test
- 10.2. Analyzers
- 11. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2026, by End User
- 11.1. Hospitals & Laboratories
- 11.2. Clinics
- 11.3. Diagnostic Centers
- 11.4. Others
- 12. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2026, by Region
- 12.1. North America
- 12.2. Latin America
- 12.3. Europe
- 12.4. East Asia
- 12.5. South Asia
- 12.6. Oceania
- 12.7. Middle East and Africa (MEA)
- 13. North America Market Analysis 2017 to 2021 and Forecast 2022 to 2026
- 14. Latin America Market Analysis 2017 to 2021 and Forecast 2022 to 2026
- 15. Europe Market Analysis 2017 to 2021 and Forecast 2022 to 2026
- 16. South Asia Market Analysis 2017 to 2021 and Forecast 2022 to 2026
- 17. East Asia Market Analysis 2017 to 2021 and Forecast 2022 to 2026
- 18. Oceania Market Analysis 2017 to 2021 and Forecast 2022 to 2026
- 19. Middle East and Africa Market Analysis 2017 to 2021 and Forecast 2022 to 2026
- 20. Key and Emerging Countries Market Analysis 2017 to 2021 and Forecast 2022 to 2026
- 21. Market Structure Analysis
- 22. Competition Analysis
- 22.1. LifeSign LLC
- 22.2. Medtronic plc
- 22.3. Nano-Ditech Corporation
- 22.4. Nexus Dx, Inc.
- 22.5. PTS Diagnostics
- 22.6. Bio-Rad Laboratories, Inc.
- 22.7. F. Hoffmann-La Roche AG
- 22.8. Nova Biomedical Corporation
- 22.9. Danaher Corporation
- 22.10. Sekisui Medical Co., Ltd.
- 23. Assumptions and Acronyms Used
- 24. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Market Volume (‘000 Units) Analysis and Opportunity Assessment 2017 to 2026, By Product
Table 02: Global Market Value (US$ Mn) Analysis and Opportunity Assessment 2017 to 2026, By Product
Table 03: Global Market Value (US$ Mn) Analysis and Opportunity Assessment 2017 to 2026, By End User
Table 04: Global Market Value (US$ Mn) Analysis and Opportunity Assessment 2017 to 2026, By Region
Table 05: North America Market Value (US$ Mn) Analysis 2017 to 2021 and Forecast 2022 to 2026, By Country
Table 06: North America Market Value (US$ Mn) Analysis and Opportunity Assessment 2017 to 2026, By Product
Table 07: North America Market Value (US$ Mn) Analysis and Opportunity Assessment 2017 to 2026, By End User
Table 08: Latin America Market Value (US$ Mn) Analysis 2017 to 2021 and Forecast 2022 to 2026, By Country
Table 09: Latin America Market Value (US$ Mn) Analysis and Opportunity Assessment 2017 to 2026, By Product
Table 10: Latin America Market Value (US$ Mn) Analysis and Opportunity Assessment 2017 to 2026, By End User
Table 11: Europe Market Value (US$ Mn) Analysis 2017 to 2021 and Forecast 2022 to 2026, By Country
Table 12: Europe Market Value (US$ Mn) Analysis and Opportunity Assessment 2017 to 2026, By Product
Table 13: Europe Market Value (US$ Mn) Analysis and Opportunity Assessment 2017 to 2026, By End User
Table 14: South Asia Market Value (US$ Mn) Analysis 2017 to 2021 and Forecast 2022 to 2026, By Country
Table 15: South Asia Market Value (US$ Mn) Analysis and Opportunity Assessment 2017 to 2026, By Product
Table 16: South Asia Market Value (US$ Mn) Analysis and Opportunity Assessment 2017 to 2026, By End User
Table 17: East Asia Market Value (US$ Mn) Analysis 2017 to 2021 and Forecast 2022 to 2026, By Country
Table 18: East Asia Market Value (US$ Mn) Analysis and Opportunity Assessment 2017 to 2026, By Product
Table 19: East Asia Market Value (US$ Mn) Analysis and Opportunity Assessment 2017 to 2026, By End User
Table 20: Oceania Market Value (US$ Mn) Analysis 2017 to 2021 and Forecast 2022 to 2026, By Country
Table 21: Oceania Market Value (US$ Mn) Analysis and Opportunity Assessment 2017 to 2026, By Product
Table 22: Oceania Market Value (US$ Mn) Analysis and Opportunity Assessment 2017 to 2026, By End User
Table 23: Middle East and Africa Market Value (US$ Mn) Analysis 2017 to 2021 and Forecast 2022 to 2026, By Country
Table 24: Middle East and Africa Market Value (US$ Mn) Analysis and Opportunity Assessment 2017 to 2026, By Product
Table 25: Middle East and Africa Market Value (US$ Mn) Analysis and Opportunity Assessment 2017 to 2026, By End User
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global Market Volume (in 000' Units) Analysis, 2017 to 2021
Figure 02: Global Market Volume Forecast (in 000' Units), 2022 to 2026
Figure 03: Pricing Analysis (US$) Per Product Type, By Region, 2021
Figure 04: Pricing Analysis (US$) Per Product Type, By Region, 2021
Figure 05: Global Market Value Analysis (US$ Mn), 2017 to 2021
Figure 06: Global Market Value Forecast (US$ Mn), 2022 to 2026
Figure 07: Global Market Absolute $ Opportunity, 2022 to 2026
Figure 08: Global Market Share Analysis (%), By Product, 2022 to 2026
Figure 09: Global Market Y-o-Y Analysis (%), By Product, 2022 to 2026
Figure 10: Global Market Attractiveness Analysis by Product, 2022 to 2026
Figure 11: Global Market Share Analysis (%), By End User, 2022 to 2026
Figure 12: Global Market Y-o-Y Analysis (%), By End User, 2022 to 2026
Figure 13: Global Market Attractiveness Analysis by End User, 2022 to 2026
Figure 14: Global Market Share Analysis (%), By Region, 2022 to 2026
Figure 15: Global Market Y-o-Y Analysis (%), By Region, 2022 to 2026
Figure 16: Global Market Attractiveness Analysis by Region, 2022 to 2026
Figure 17: North America Market Value Share, By Product, 2022 (E)
Figure 18: North America Market Value Share, By End User, 2022 (E)
Figure 19: North America Market Value Share, By Country, 2022 (E)
Figure 20: North America Market Value Analysis (US$ Mn), 2017 to 2021
Figure 21: North America Market Value Forecast (US$ Mn), 2022 to 2026
Figure 22: North America Market Attractiveness Analysis by Product, 2022 to 2026
Figure 23: North America Market Attractiveness Analysis by End User, 2022 to 2026
Figure 24: North America Market Attractiveness Analysis by Country, 2022 to 2026
Figure 25: Latin America Market Value Share, By Product, 2022 (E)
Figure 26: Latin America Market Value Share, By End User, 2022 (E)
Figure 27: Latin America Market Value Share, By Country, 2022 (E)
Figure 28: Latin America Market Value Analysis (US$ Mn), 2017 to 2021
Figure 29: Latin America Market Value Forecast (US$ Mn), 2022 to 2026
Figure 30: Latin America Market Attractiveness Analysis by Product, 2022 to 2026
Figure 31: Latin America Market Attractiveness Analysis by End User, 2022 to 2026
Figure 32: Latin America Market Attractiveness Analysis by Country, 2022 to 2026
Figure 33: Europe Market Value Share, By Product, 2022 (E)
Figure 34: Europe Market Value Share, By End User, 2022 (E)
Figure 35: Europe Market Value Share, By Country, 2022 (E)
Figure 36: Europe Market Value Analysis (US$ Mn), 2017 to 2021
Figure 37: Europe Market Value Forecast (US$ Mn), 2022 to 2026
Figure 38: Europe Market Attractiveness Analysis by Product, 2022 to 2026
Figure 39: Europe Market Attractiveness Analysis by End User, 2022 to 2026
Figure 40: Europe Market Attractiveness Analysis by Country, 2022 to 2026
Figure 41: South Asia Market Value Share, By Product, 2022 (E)
Figure 42: South Asia Market Value Share, By End User, 2022 (E)
Figure 43: South Asia Market Value Share, By Country, 2022 (E)
Figure 44: South Asia Market Value Analysis (US$ Mn), 2017 to 2021
Figure 45: South Asia Market Value Forecast (US$ Mn), 2022 to 2026
Figure 46: South Asia Market Attractiveness Analysis by Product, 2022 to 2026
Figure 47: South Asia Market Attractiveness Analysis by End User, 2022 to 2026
Figure 48: South Asia Market Attractiveness Analysis by Country, 2022 to 2026
Figure 49: East Asia Market Value Share, By Product, 2022 (E)
Figure 50: East Asia Market Value Share, By End User, 2022 (E)
Figure 51: East Asia Market Value Share, By Country, 2022 (E)
Figure 52: East Asia Market Value Analysis (US$ Mn), 2017 to 2021
Figure 53: East Asia Market Value Forecast (US$ Mn), 2022 to 2026
Figure 54: East Asia Market Attractiveness Analysis by Product, 2022 to 2026
Figure 55: East Asia Market Attractiveness Analysis by End User, 2022 to 2026
Figure 56: East Asia Market Attractiveness Analysis by Country, 2022 to 2026
Figure 57: Oceania Market Value Share, By Product, 2022 (E)
Figure 58: Oceania Market Value Share, By End User, 2022 (E)
Figure 59: Oceania Market Value Share, By Country, 2022 (E)
Figure 60: Oceania Market Value Analysis (US$ Mn), 2017 to 2021
Figure 61: Oceania Market Value Forecast (US$ Mn), 2022 to 2026
Figure 62: Oceania Market Attractiveness Analysis by Product, 2022 to 2026
Figure 63: Oceania Market Attractiveness Analysis by End User, 2022 to 2026
Figure 64: Oceania Market Attractiveness Analysis by Country, 2022 to 2026
Figure 65: Middle East and Africa Market Value Share, By Product, 2022 (E)
Figure 66: Middle East and Africa Market Value Share, By End User, 2022 (E)
Figure 67: Middle East and Africa Market Value Share, By Country, 2022 (E)
Figure 68: Middle East and Africa Market Value Analysis (US$ Mn), 2017 to 2021
Figure 69: Middle East and Africa Market Value Forecast (US$ Mn), 2022 to 2026
Figure 70: Middle East and Africa Market Attractiveness Analysis by Product, 2022 to 2026
Figure 71: Middle East and Africa Market Attractiveness Analysis by End User, 2022 to 2026
Figure 72: Middle East and Africa Market Attractiveness Analysis by Country, 2022 to 2026
Figure 73: U. S. Market Value Analysis (US$ Mn), 2022 & 2026
Figure 74: U. S. Market Value Share, By Product, 2022 (E)
Figure 75: U. S. Market Value Share, By End User, 2022 (E)
Figure 76: Canada Market Value Analysis (US$ Mn), 2022 & 2026
Figure 77: Canada Market Value Share, By Product, 2022 (E)
Figure 78: Canada Market Value Share, By End User, 2022 (E)
Figure 79: Mexico Market Value Analysis (US$ Mn), 2022 & 2026
Figure 80: Mexico Market Value Share, By Product, 2022 (E)
Figure 81: Mexico Market Value Share, By End User, 2022 (E)
Figure 82: Brazil Market Value Analysis (US$ Mn), 2022 & 2026
Figure 83: Brazil Market Value Share, By Product, 2022 (E)
Figure 84: Brazil Market Value Share, By End User, 2022 (E)
Figure 85: U. K. Market Value Analysis (US$ Mn), 2022 & 2026
Figure 86: U. K. Market Value Share, By Product, 2022 (E)
Figure 87: U. K. Market Value Share, By End User, 2022 (E)
Figure 88: Germany Market Value Analysis (US$ Mn), 2022 & 2026
Figure 89: Germany Market Value Share, By Product, 2022 (E)
Figure 90: Germany Market Value Share, By End User, 2022 (E)
Figure 91: France Market Value Analysis (US$ Mn), 2022 & 2026
Figure 92: France Market Value Share, By Product, 2022 (E)
Figure 93: France Market Value Share, By End User, 2022 (E)
Figure 94: Italy Market Value Analysis (US$ Mn), 2022 & 2026
Figure 95: Italy Market Value Share, By Product, 2022 (E)
Figure 96: Italy Market Value Share, By End User, 2022 (E)
Figure 97: Spain Market Value Analysis (US$ Mn), 2022 & 2026
Figure 98: Spain Market Value Share, By Product, 2022 (E)
Figure 99: Spain Market Value Share, By End User, 2022 (E)
Figure 100: Russia Market Value Analysis (US$ Mn), 2022 & 2026
Figure 101: Russia Market Value Share, By Product, 2022 (E)
Figure 102: Russia Market Value Share, By End User, 2022 (E)
Figure 103: China Market Value Analysis (US$ Mn), 2022 & 2026
Figure 104: China Market Value Share, By Product, 2022 (E)
Figure 105: China Market Value Share, By End User, 2022 (E)
Figure 106: Japan Market Value Analysis (US$ Mn), 2022 & 2026
Figure 107: Japan Market Value Share, By Product, 2022 (E)
Figure 108: Japan Market Value Share, By End User, 2022 (E)
Figure 109: South Korea Market Value Analysis (US$ Mn), 2022 & 2026
Figure 110: South Korea Market Value Share, By Product, 2022 (E)
Figure 111: South Korea Market Value Share, By End User, 2022 (E)
Figure 112: India Market Value Analysis (US$ Mn), 2022 & 2026
Figure 113: India Market Value Share, By Product, 2022 (E)
Figure 114: India Market Value Share, By End User, 2022 (E)
Figure 115: ASEAN Market Value Analysis (US$ Mn), 2022 & 2026
Figure 116: ASEAN Market Value Share, By Product, 2022 (E)
Figure 117: ASEAN Market Value Share, By End User, 2022 (E)
Figure 118: Australia Market Value Analysis (US$ Mn), 2022 & 2026
Figure 119: Australia Market Value Share, By Product, 2022 (E)
Figure 120: Australia Market Value Share, By End User, 2022 (E)
Figure 121: New Zealand Market Value Analysis (US$ Mn), 2022 & 2026
Figure 122: New Zealand Market Value Share, By Product, 2022 (E)
Figure 123: New Zealand Market Value Share, By End User, 2022 (E)
Figure 124: GCC Countries Market Value Analysis (US$ Mn), 2022 & 2026
Figure 125: GCC Countries Market Value Share, By Product, 2022 (E)
Figure 126: GCC Countries Market Value Share, By End User, 2022 (E)
Figure 127: Turkey Market Value Analysis (US$ Mn), 2022 & 2026
Figure 128: Turkey Market Value Share, By Product, 2022 (E)
Figure 129: Turkey Market Value Share, By End User, 2022 (E)
Figure 130: South Africa Market Value Analysis (US$ Mn), 2022 & 2026
Figure 131: South Africa Market Value Share, By Product, 2022 (E)
Figure 132: South Africa Market Value Share, By End User, 2022 (E)
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
What is the current market value of cardiac POC testing devices?
The global cardiac POC testing devices market currently accounts for a valuation of US$ 1.5 billion.
What is the estimated CAGR for the cardiac POC testing devices market?
The market for cardiac POC testing devices is set to expand at 6% CAGR through 2026.
Which are the top cardiac POC testing device manufacturers?
LifeSign LLC, Medtronic plc, and Nexus Dx, Inc. are key cardiac POC testing system manufacturers.
What valuation will the market reach by 2026?
Sales of cardiac POC testing devices are expected to reach US$ 1.9 billion by 2026.
What is the estimated CAGR for the market in Japan?
The cardiac POC testing devices market in Japan is set to rise at 4.7% CAGR.